[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Neurological Biomarkers Sales Market Report 2017

December 2017 | 118 pages | ID: GE068DD6C48EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Neurological Biomarkers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Neurological Biomarkers for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Neurological Biomarkers market competition by top manufacturers/players, with Neurological Biomarkers sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Thermo Fisher Scientific (U.S.)
  • Qiagen (Germany)
  • Myriad RBM (U.S.)
  • Proteome Sciences (UK)
  • Banyan Biomarkers (U.S.)
  • Cisbio Bioassays (U.S.)
  • Abiant (U.S.)
  • Acumen Pharmaceuticals (U.S.)
  • Proteosys (Germany)
  • Alseres Pharmaceuticals (U.S.)
  • Athena Diagnostics (U.S.)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Alzheimer's Disease
  • Parkinson's Disease
  • Autism Spectrum Disorder
  • Multiple Sclerosis
  • Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Genomics
  • Proteomics
  • Metabolomics
  • Imaging
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Neurological Biomarkers Sales Market Report 2017

1 NEUROLOGICAL BIOMARKERS MARKET OVERVIEW

1.1 Product Overview and Scope of Neurological Biomarkers
1.2 Classification of Neurological Biomarkers by Product Category
  1.2.1 Global Neurological Biomarkers Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Neurological Biomarkers Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Alzheimer's Disease
  1.2.4 Parkinson's Disease
  1.2.5 Autism Spectrum Disorder
  1.2.6 Multiple Sclerosis
  1.2.7 Other
1.3 Global Neurological Biomarkers Market by Application/End Users
  1.3.1 Global Neurological Biomarkers Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Genomics
  1.3.3 Proteomics
  1.3.4 Metabolomics
  1.3.5 Imaging
  1.3.6 Other
1.4 Global Neurological Biomarkers Market by Region
  1.4.1 Global Neurological Biomarkers Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Neurological Biomarkers Status and Prospect (2012-2022)
  1.4.3 China Neurological Biomarkers Status and Prospect (2012-2022)
  1.4.4 Europe Neurological Biomarkers Status and Prospect (2012-2022)
  1.4.5 Japan Neurological Biomarkers Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Neurological Biomarkers Status and Prospect (2012-2022)
  1.4.7 India Neurological Biomarkers Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Neurological Biomarkers (2012-2022)
  1.5.1 Global Neurological Biomarkers Sales and Growth Rate (2012-2022)
  1.5.2 Global Neurological Biomarkers Revenue and Growth Rate (2012-2022)

2 GLOBAL NEUROLOGICAL BIOMARKERS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Neurological Biomarkers Market Competition by Players/Suppliers
  2.1.1 Global Neurological Biomarkers Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Neurological Biomarkers Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Neurological Biomarkers (Volume and Value) by Type
  2.2.1 Global Neurological Biomarkers Sales and Market Share by Type (2012-2017)
  2.2.2 Global Neurological Biomarkers Revenue and Market Share by Type (2012-2017)
2.3 Global Neurological Biomarkers (Volume and Value) by Region
  2.3.1 Global Neurological Biomarkers Sales and Market Share by Region (2012-2017)
  2.3.2 Global Neurological Biomarkers Revenue and Market Share by Region (2012-2017)
2.4 Global Neurological Biomarkers (Volume) by Application

3 UNITED STATES NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Neurological Biomarkers Sales and Value (2012-2017)
  3.1.1 United States Neurological Biomarkers Sales and Growth Rate (2012-2017)
  3.1.2 United States Neurological Biomarkers Revenue and Growth Rate (2012-2017)
  3.1.3 United States Neurological Biomarkers Sales Price Trend (2012-2017)
3.2 United States Neurological Biomarkers Sales Volume and Market Share by Players
3.3 United States Neurological Biomarkers Sales Volume and Market Share by Type
3.4 United States Neurological Biomarkers Sales Volume and Market Share by Application

4 CHINA NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

4.1 China Neurological Biomarkers Sales and Value (2012-2017)
  4.1.1 China Neurological Biomarkers Sales and Growth Rate (2012-2017)
  4.1.2 China Neurological Biomarkers Revenue and Growth Rate (2012-2017)
  4.1.3 China Neurological Biomarkers Sales Price Trend (2012-2017)
4.2 China Neurological Biomarkers Sales Volume and Market Share by Players
4.3 China Neurological Biomarkers Sales Volume and Market Share by Type
4.4 China Neurological Biomarkers Sales Volume and Market Share by Application

5 EUROPE NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Neurological Biomarkers Sales and Value (2012-2017)
  5.1.1 Europe Neurological Biomarkers Sales and Growth Rate (2012-2017)
  5.1.2 Europe Neurological Biomarkers Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Neurological Biomarkers Sales Price Trend (2012-2017)
5.2 Europe Neurological Biomarkers Sales Volume and Market Share by Players
5.3 Europe Neurological Biomarkers Sales Volume and Market Share by Type
5.4 Europe Neurological Biomarkers Sales Volume and Market Share by Application

6 JAPAN NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Neurological Biomarkers Sales and Value (2012-2017)
  6.1.1 Japan Neurological Biomarkers Sales and Growth Rate (2012-2017)
  6.1.2 Japan Neurological Biomarkers Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Neurological Biomarkers Sales Price Trend (2012-2017)
6.2 Japan Neurological Biomarkers Sales Volume and Market Share by Players
6.3 Japan Neurological Biomarkers Sales Volume and Market Share by Type
6.4 Japan Neurological Biomarkers Sales Volume and Market Share by Application

7 SOUTHEAST ASIA NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Neurological Biomarkers Sales and Value (2012-2017)
  7.1.1 Southeast Asia Neurological Biomarkers Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Neurological Biomarkers Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Neurological Biomarkers Sales Price Trend (2012-2017)
7.2 Southeast Asia Neurological Biomarkers Sales Volume and Market Share by Players
7.3 Southeast Asia Neurological Biomarkers Sales Volume and Market Share by Type
7.4 Southeast Asia Neurological Biomarkers Sales Volume and Market Share by Application

8 INDIA NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE)

8.1 India Neurological Biomarkers Sales and Value (2012-2017)
  8.1.1 India Neurological Biomarkers Sales and Growth Rate (2012-2017)
  8.1.2 India Neurological Biomarkers Revenue and Growth Rate (2012-2017)
  8.1.3 India Neurological Biomarkers Sales Price Trend (2012-2017)
8.2 India Neurological Biomarkers Sales Volume and Market Share by Players
8.3 India Neurological Biomarkers Sales Volume and Market Share by Type
8.4 India Neurological Biomarkers Sales Volume and Market Share by Application

9 GLOBAL NEUROLOGICAL BIOMARKERS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Thermo Fisher Scientific (U.S.)
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Neurological Biomarkers Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Qiagen (Germany)
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Neurological Biomarkers Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Qiagen (Germany) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Myriad RBM (U.S.)
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Neurological Biomarkers Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Myriad RBM (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Proteome Sciences (UK)
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Neurological Biomarkers Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Proteome Sciences (UK) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Banyan Biomarkers (U.S.)
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Neurological Biomarkers Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Banyan Biomarkers (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Cisbio Bioassays (U.S.)
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Neurological Biomarkers Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Cisbio Bioassays (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Abiant (U.S.)
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Neurological Biomarkers Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Abiant (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Acumen Pharmaceuticals (U.S.)
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Neurological Biomarkers Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Proteosys (Germany)
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Neurological Biomarkers Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Proteosys (Germany) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Alseres Pharmaceuticals (U.S.)
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Neurological Biomarkers Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Athena Diagnostics (U.S.)

10 NEUROLOGICAL BIOMARKERS MAUFACTURING COST ANALYSIS

10.1 Neurological Biomarkers Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Neurological Biomarkers
10.3 Manufacturing Process Analysis of Neurological Biomarkers

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Neurological Biomarkers Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Neurological Biomarkers Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL NEUROLOGICAL BIOMARKERS MARKET FORECAST (2017-2022)

14.1 Global Neurological Biomarkers Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Neurological Biomarkers Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Neurological Biomarkers Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Neurological Biomarkers Price and Trend Forecast (2017-2022)
14.2 Global Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Neurological Biomarkers Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Neurological Biomarkers Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Neurological Biomarkers Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Neurological Biomarkers Sales Forecast by Type (2017-2022)
  14.3.2 Global Neurological Biomarkers Revenue Forecast by Type (2017-2022)
  14.3.3 Global Neurological Biomarkers Price Forecast by Type (2017-2022)
14.4 Global Neurological Biomarkers Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Neurological Biomarkers
Figure Global Neurological Biomarkers Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Neurological Biomarkers Sales Volume Market Share by Type (Product Category) in 2016
Figure Alzheimer's Disease Product Picture
Figure Parkinson's Disease Product Picture
Figure Autism Spectrum Disorder Product Picture
Figure Multiple Sclerosis Product Picture
Figure Other Product Picture
Figure Global Neurological Biomarkers Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Neurological Biomarkers by Application in 2016
Figure Genomics Examples
Table Key Downstream Customer in Genomics
Figure Proteomics Examples
Table Key Downstream Customer in Proteomics
Figure Metabolomics Examples
Table Key Downstream Customer in Metabolomics
Figure Imaging Examples
Table Key Downstream Customer in Imaging
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Neurological Biomarkers Market Size (Million USD) by Regions (2012-2022)
Figure United States Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Neurological Biomarkers Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Neurological Biomarkers Sales Volume (K Pcs) (2012-2017)
Table Global Neurological Biomarkers Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Neurological Biomarkers Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Neurological Biomarkers Sales Share by Players/Suppliers
Figure 2017 Neurological Biomarkers Sales Share by Players/Suppliers
Figure Global Neurological Biomarkers Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Neurological Biomarkers Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Neurological Biomarkers Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Neurological Biomarkers Revenue Share by Players
Table 2017 Global Neurological Biomarkers Revenue Share by Players
Table Global Neurological Biomarkers Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Neurological Biomarkers Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Neurological Biomarkers by Type (2012-2017)
Figure Global Neurological Biomarkers Sales Growth Rate by Type (2012-2017)
Table Global Neurological Biomarkers Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Neurological Biomarkers Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Neurological Biomarkers by Type (2012-2017)
Figure Global Neurological Biomarkers Revenue Growth Rate by Type (2012-2017)
Table Global Neurological Biomarkers Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Neurological Biomarkers Sales Share by Region (2012-2017)
Figure Sales Market Share of Neurological Biomarkers by Region (2012-2017)
Figure Global Neurological Biomarkers Sales Growth Rate by Region in 2016
Table Global Neurological Biomarkers Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Neurological Biomarkers Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Neurological Biomarkers by Region (2012-2017)
Figure Global Neurological Biomarkers Revenue Growth Rate by Region in 2016
Table Global Neurological Biomarkers Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Neurological Biomarkers Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Neurological Biomarkers by Region (2012-2017)
Figure Global Neurological Biomarkers Revenue Market Share by Region in 2016
Table Global Neurological Biomarkers Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Neurological Biomarkers Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Neurological Biomarkers by Application (2012-2017)
Figure Global Neurological Biomarkers Sales Market Share by Application (2012-2017)
Figure United States Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Neurological Biomarkers Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Neurological Biomarkers Sales Volume (K Pcs) by Players (2012-2017)
Table United States Neurological Biomarkers Sales Volume Market Share by Players (2012-2017)
Figure United States Neurological Biomarkers Sales Volume Market Share by Players in 2016
Table United States Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2017)
Table United States Neurological Biomarkers Sales Volume Market Share by Type (2012-2017)
Figure United States Neurological Biomarkers Sales Volume Market Share by Type in 2016
Table United States Neurological Biomarkers Sales Volume (K Pcs) by Application (2012-2017)
Table United States Neurological Biomarkers Sales Volume Market Share by Application (2012-2017)
Figure United States Neurological Biomarkers Sales Volume Market Share by Application in 2016
Figure China Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Neurological Biomarkers Sales Price (USD/Pcs) Trend (2012-2017)
Table China Neurological Biomarkers Sales Volume (K Pcs) by Players (2012-2017)
Table China Neurological Biomarkers Sales Volume Market Share by Players (2012-2017)
Figure China Neurological Biomarkers Sales Volume Market Share by Players in 2016
Table China Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2017)
Table China Neurological Biomarkers Sales Volume Market Share by Type (2012-2017)
Figure China Neurological Biomarkers Sales Volume Market Share by Type in 2016
Table China Neurological Biomarkers Sales Volume (K Pcs) by Application (2012-2017)
Table China Neurological Biomarkers Sales Volume Market Share by Application (2012-2017)
Figure China Neurological Biomarkers Sales Volume Market Share by Application in 2016
Figure Europe Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Neurological Biomarkers Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Neurological Biomarkers Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Neurological Biomarkers Sales Volume Market Share by Players (2012-2017)
Figure Europe Neurological Biomarkers Sales Volume Market Share by Players in 2016
Table Europe Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Neurological Biomarkers Sales Volume Market Share by Type (2012-2017)
Figure Europe Neurological Biomarkers Sales Volume Market Share by Type in 2016
Table Europe Neurological Biomarkers Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Neurological Biomarkers Sales Volume Market Share by Application (2012-2017)
Figure Europe Neurological Biomarkers Sales Volume Market Share by Application in 2016
Figure Japan Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Neurological Biomarkers Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Neurological Biomarkers Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Neurological Biomarkers Sales Volume Market Share by Players (2012-2017)
Figure Japan Neurological Biomarkers Sales Volume Market Share by Players in 2016
Table Japan Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Neurological Biomarkers Sales Volume Market Share by Type (2012-2017)
Figure Japan Neurological Biomarkers Sales Volume Market Share by Type in 2016
Table Japan Neurological Biomarkers Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Neurological Biomarkers Sales Volume Market Share by Application (2012-2017)
Figure Japan Neurological Biomarkers Sales Volume Market Share by Application in 2016
Figure Southeast Asia Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Neurological Biomarkers Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Neurological Biomarkers Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Neurological Biomarkers Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Neurological Biomarkers Sales Volume Market Share by Players in 2016
Table Southeast Asia Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Neurological Biomarkers Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Neurological Biomarkers Sales Volume Market Share by Type in 2016
Table Southeast Asia Neurological Biomarkers Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Neurological Biomarkers Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Neurological Biomarkers Sales Volume Market Share by Application in 2016
Figure India Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Neurological Biomarkers Sales Price (USD/Pcs) Trend (2012-2017)
Table India Neurological Biomarkers Sales Volume (K Pcs) by Players (2012-2017)
Table India Neurological Biomarkers Sales Volume Market Share by Players (2012-2017)
Figure India Neurological Biomarkers Sales Volume Market Share by Players in 2016
Table India Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2017)
Table India Neurological Biomarkers Sales Volume Market Share by Type (2012-2017)
Figure India Neurological Biomarkers Sales Volume Market Share by Type in 2016
Table India Neurological Biomarkers Sales Volume (K Pcs) by Application (2012-2017)
Table India Neurological Biomarkers Sales Volume Market Share by Application (2012-2017)
Figure India Neurological Biomarkers Sales Volume Market Share by Application in 2016
Table Thermo Fisher Scientific (U.S.) Basic Information List
Table Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales Global Market Share (2012-2017
Figure Thermo Fisher Scientific (U.S.) Neurological Biomarkers Revenue Global Market Share (2012-2017)
Table Qiagen (Germany) Basic Information List
Table Qiagen (Germany) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Qiagen (Germany) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Qiagen (Germany) Neurological Biomarkers Sales Global Market Share (2012-2017
Figure Qiagen (Germany) Neurological Biomarkers Revenue Global Market Share (2012-2017)
Table Myriad RBM (U.S.) Basic Information List
Table Myriad RBM (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Myriad RBM (U.S.) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Myriad RBM (U.S.) Neurological Biomarkers Sales Global Market Share (2012-2017
Figure Myriad RBM (U.S.) Neurological Biomarkers Revenue Global Market Share (2012-2017)
Table Proteome Sciences (UK) Basic Information List
Table Proteome Sciences (UK) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Proteome Sciences (UK) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Proteome Sciences (UK) Neurological Biomarkers Sales Global Market Share (2012-2017
Figure Proteome Sciences (UK) Neurological Biomarkers Revenue Global Market Share (2012-2017)
Table Banyan Biomarkers (U.S.) Basic Information List
Table Banyan Biomarkers (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Banyan Biomarkers (U.S.) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Banyan Biomarkers (U.S.) Neurological Biomarkers Sales Global Market Share (2012-2017
Figure Banyan Biomarkers (U.S.) Neurological Biomarkers Revenue Global Market Share (2012-2017)
Table Cisbio Bioassays (U.S.) Basic Information List
Table Cisbio Bioassays (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cisbio Bioassays (U.S.) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Cisbio Bioassays (U.S.) Neurological Biomarkers Sales Global Market Share (2012-2017
Figure Cisbio Bioassays (U.S.) Neurological Biomarkers Revenue Global Market Share (2012-2017)
Table Abiant (U.S.) Basic Information List
Table Abiant (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abiant (U.S.) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Abiant (U.S.) Neurological Biomarkers Sales Global Market Share (2012-2017
Figure Abiant (U.S.) Neurological Biomarkers Revenue Global Market Share (2012-2017)
Table Acumen Pharmaceuticals (U.S.) Basic Information List
Table Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales Global Market Share (2012-2017
Figure Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Revenue Global Market Share (2012-2017)
Table Proteosys (Germany) Basic Information List
Table Proteosys (Germany) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Proteosys (Germany) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Proteosys (Germany) Neurological Biomarkers Sales Global Market Share (2012-2017
Figure Proteosys (Germany) Neurological Biomarkers Revenue Global Market Share (2012-2017)
Table Alseres Pharmaceuticals (U.S.) Basic Information List
Table Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales Growth Rate (2012-2017)
Figure Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales Global Market Share (2012-2017
Figure Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Revenue Global Market Share (2012-2017)
Table Athena Diagnostics (U.S.) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurological Biomarkers
Figure Manufacturing Process Analysis of Neurological Biomarkers
Figure Neurological Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Neurological Biomarkers Major Players in 2016
Table Major Buyers of Neurological Biomarkers
Table Distributors/Traders List
Figure Global Neurological Biomarkers Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Neurological Biomarkers Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Neurological Biomarkers Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Neurological Biomarkers Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Neurological Biomarkers Sales Volume Market Share Forecast by Regions in 2022
Table Global Neurological Biomarkers Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Neurological Biomarkers Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Neurological Biomarkers Revenue Market Share Forecast by Regions in 2022
Figure United States Neurological Biomarkers Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Neurological Biomarkers Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Neurological Biomarkers Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Neurological Biomarkers Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Neurological Biomarkers Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Neurological Biomarkers Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Neurological Biomarkers Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Neurological Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Neurological Biomarkers Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Neurological Biomarkers Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Neurological Biomarkers Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Neurological Biomarkers Revenue Market Share Forecast by Type (2017-2022)
Table Global Neurological Biomarkers Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Neurological Biomarkers Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Neurological Biomarkers Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories